Presentation TCT 2023 CTO PCI When Is It Indicated? Review of the Evidence Presenter: Robert Yeh October 26, 2023
Presentation TCT 2023 Applying The Evidence to Clinical Practice: Do Cut Points Matter? Presenter: Nils Johnson October 26, 2023
Presentation TCT 2023 Coronary Keynote Lecture: Evidence-Based Contemporary Options for Treatment of In-Stent Restenosis Presenter: Franz Kleber October 25, 2023
Presentation TCT 2023 STEMI Pharmacotherapy: Oral and IV Antiplatelet Therapies, Intracoronary Lytic, Anticoagulants, and Early PCSK9 Inhibitors Presenter: Sanjit Jolly October 25, 2023
Presentation TCT 2023 Addressing Microvascular Obstruction with SSO2 Presenter: Gregg Stone October 25, 2023
News Conference News TCT 2023 In ACS, Ticagrelor Only After < 1 Month DAPT Beats Continuing Aspirin: T-PASS Yael L. Maxwell October 25, 2023
Presentation TCT 2023 Reperfusion of the Infarct Related Artery With Timely Primary PCI Presenter: Cindy Grines October 25, 2023
News Conference News TCT 2023 ‘Light at the End of the Tunnel’ for In-Stent Restenosis: AGENT IDE Wins Big Todd Neale October 25, 2023
Presentation TCT 2023 Staged NCL PCI Is Safer and Better for the Patient! Presenter: David Wood October 25, 2023
Presentation TCT 2023 Immediate NCL PCI Is the Way to Go! Presenter: Nicolas Van Mieghem October 25, 2023
Presentation TCT 2023 Complete Revascularization in Patients With STEMI and MVD: CV Outcomes, Quality of Life, and Future Directions Presenter: Shamir Mehta October 25, 2023
Presentation TCT 2023 Hypertension Care Pathway with uRDN: Experiences from Clinical Trials Presenter: NULL October 25, 2023
Presentation TCT 2023 A High Standard of Clinical Evidence: Recent Key Milestones Presenter: NULL October 25, 2023
Presentation TCT 2023 Bivalirudin Is the Most Evidence Based Antithrombin Agent for Primary PCI Presenter: Gregg Stone October 25, 2023